<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02623777</url>
  </required_header>
  <id_info>
    <org_study_id>s57413</org_study_id>
    <nct_id>NCT02623777</nct_id>
  </id_info>
  <brief_title>Effect of Arabinoxylan Oligosaccharides Consumption on Insulin Resistance in Patients With Metabolic Syndrome</brief_title>
  <official_title>Evaluation of the Effect of Arabinoxylan Oligosaccharides Consumption on Insulin Resistance in Patients With Metabolic Syndrome and the Contribution of Short-chain Fatty Acids Production</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Katholieke Universiteit Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Katholieke Universiteit Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      During this project the investigators will evaluate whether the effects of arabinoxylan
      oligosaccharides (AXOS) consumption on insulin resistance in participants with metabolic
      syndrome can be explained by the production of short-chain fatty acids (SCFA). Secondly, the
      investigators will evaluate whether changes in gut hormone production might explain the
      effect on insulin resistance.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Actual">November 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in insulin resistance after both interventions using the homeostatic model assessment for insulin resistance</measure>
    <time_frame>2 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">9</enrollment>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>AXOS as first intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>AXOS as first intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SCFA as first intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>SCFA as first intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Arabinoxylan oligosaccharides</intervention_name>
    <description>Arabinoxylan oligosaccharides administered</description>
    <arm_group_label>AXOS as first intervention</arm_group_label>
    <arm_group_label>SCFA as first intervention</arm_group_label>
    <other_name>AXOS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Short chain fatty acids</intervention_name>
    <description>Short chain fatty acids administered</description>
    <arm_group_label>AXOS as first intervention</arm_group_label>
    <arm_group_label>SCFA as first intervention</arm_group_label>
    <other_name>SCFA</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 18 and 65 years

          -  Regular diet (3 meals/day on at least 5 days/week)

          -  Central obese (defined as waist circumference ≥ 94cm for Europid men and ≥ 80cm for
             Europid women, with ethnicity specific values for other groups)

          -  Insulin resistant: HOMA-IR &gt; 1.7 or fasting glucose &gt; 100mg/dL

          -  And one of the following three factors:

               -  Elevated TG level: ≥ 150 mg/dL (1.7 mmol/L)

               -  Decreased HDL cholesterol level: &lt; 40 mg/dL (1.03 mmol/L*) in males and &lt; 50
                  mg/dL (1.29 mmol/L*) in females

               -  Elevated blood pressure (BP): systolic BP ≥ 130 or diastolic BP ≥ 85 mm Hg

        Exclusion Criteria:

          -  Low calorie diet or other special diet during the study or during the last month prior
             to the study

          -  Serious chronic disease of the gastrointestinal tract, such as inflammatory bowel
             disease (Crohn's disease or ulcerative colitis), irritable bowel syndrome, chronic
             constipation (less than 3 bowel movements a week), chronic frequent diarrhoea (more
             than 3 stools a day), clinically relevant lactose intolerance, …

          -  Use of antibiotics during the last month before starting the study

          -  Abdominal surgery in the past (except from appendectomy)

          -  Use of medication that affects the gastro-intestinal tract during the last 2 weeks
             prior to the study including spasmolytics, anti-diarrhoea medication,
             anti-constipation medication, and/or pre- or probiotic supplements (e.g. lacteol,
             Enterol)

          -  Pregnancy, pregnancy desire or lactation

          -  Diabetes (type 1 or 2), i.e. HbA1c &gt; 6.5 %

          -  Abnormal haemoglobin (Hb) levels in blood, men must have an Hb level between 14.0 and
             18.0 g / dL and women between 12.0 and 16.0 g / dL.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 28, 2015</study_first_submitted>
  <study_first_submitted_qc>December 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 8, 2015</study_first_posted>
  <last_update_submitted>December 3, 2015</last_update_submitted>
  <last_update_submitted_qc>December 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Katholieke Universiteit Leuven</investigator_affiliation>
    <investigator_full_name>Kristin Verbeke</investigator_full_name>
    <investigator_title>Prof. Kristin Verbeke</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

